1990 …2024

Research activity per year

Personal profile

Main research areas

Understanding the type 1 diabetes pathogenesis; identifying biomarkers for disease prediction, better diagnosis and treatment monitoring. Studies of the role of non-coding RNAs in health and disease biology. Detailed studies of beta-cell biology.

Potential conflicts of interest

None

Current research

Identification of biomarkers for type 1 diabetes prediction, diagnosis, progression and treatment response. INNODIA partner (IMI2 project) focusing on translational aspects of beta-cell and immunology research in type 1 diabetes. Lipidomics and metabolomics profiling in pre-diabetic individuals. Is there a role for epigenetics in type 1 diabetes development. Identification of novel non-coding RNAs in type 1 diabetes and inflammatory bowel disease. EU/InterReg project DiaUnion is an innitiative the Oresund region to increase knowledge on biomarkers suitable for type 1 diabetes screening.

Clinical intervention trials in individuals with newly diagnosed type 1 diabetes. 

Expertises

Autoimmunity with specific emphasis on type 1 diabetes; genetics; epigenetics; lipidomics; metabolomics; beta-cell biology; immunology; cellular and molecular biology; non-coding RNAs; bioinformatics

External positions

University of Copenhagen

2005 → …

University of Copenhagen

Fingerprint

Dive into the research topics where Flemming Pociot is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
  • 1 Similar Profiles

Collaborations and top research areas from the last five years

Recent external collaboration on country/territory level. Dive into details by clicking on the dots or